What is the dose of Colesevelam HCl (bile acid sequestrant) for adults with primary hyperlipidemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dose of Colesevelam HCl for adults with primary hyperlipidemia is 3.75 grams daily, taken as either six 625 mg tablets once daily or three 625 mg tablets twice daily with meals. Alternatively, it can be administered as one 3.75-gram packet of powder once daily or one 1.875-gram packet twice daily, mixed with 4-8 ounces of water, fruit juice, or diet soft drinks. Colesevelam works by binding bile acids in the intestine, preventing their reabsorption and increasing fecal excretion, as described in the 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering 1. This forces the liver to convert more cholesterol into bile acids, thereby reducing cholesterol levels in the bloodstream. The medication should be taken with meals to enhance its effectiveness. Patients should maintain adequate fluid intake while using Colesevelam and be aware that it may cause constipation as a side effect. It's also important to note that Colesevelam may interact with other medications by reducing their absorption, so other drugs should be taken at least 4 hours before or after Colesevelam, as indicated in the study 1. Key considerations for prescribing Colesevelam include:

  • Pill burden and inconvenience in preparation of oral suspension preparations
  • GI side effects, such as constipation, dyspepsia, and nausea
  • Exacerbation of hypertriglyceridemia
  • Potential for decreased absorption of other medications
  • Importance of maintaining adequate fluid intake to minimize the risk of intestinal blockage. Overall, the recommended dose and administration of Colesevelam HCl should be individualized based on patient-specific factors and medical history, with careful consideration of potential interactions and side effects, as outlined in the 2022 ACC expert consensus decision pathway 1.

From the FDA Drug Label

2.2 Recommended Dosage in Primary Hyperlipidemia The recommended dosage of colesevelam hydrochloride for adults and for boys and postmenarchal girls aged 10 to 17 years with primary hyperlipidemia is 3.75 grams daily.

The dose of Colesevelam HCl for adults with primary hyperlipidemia is 3.75 grams daily 2.

From the Research

Dose of Colesevelam HCl

The dose of Colesevelam HCl for adults with primary hyperlipidemia is as follows:

  • The maintenance dosage is three 625-mg tablets twice daily or six tablets once daily, taken with meals 3
  • Colesevelam can be uptitrated to a maximum dosage of 3.75 g/day as necessary to achieve a 15-30% reduction from baseline in LDL-C level 4
  • In some studies, subjects received 3.75 g/day colesevelam 5, 6, 7

Key Points

  • Colesevelam HCl is a bile acid sequestrant that lowers low-density lipoprotein cholesterol (LDL-C) in hyperlipidemia and improves glycemic control in adults with type 2 diabetes 5, 6
  • The maximum dosage of colesevelam (3.75 g/day) was taken by 50% of subjects at week 50 in one study 4
  • Colesevelam has been shown to be safe and effective for the management of LDL-C levels in adults with primary hypercholesterolemia 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Colesevelam hydrochloride.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002

Research

A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010

Research

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010

Research

The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.